The current valuation score of Amphastar Pharmaceuticals Inc is 8.20, ranking 66 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 11.66, which is 164.53% below the recent high of 30.86 and 37.18% above the recent low of 7.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.